Arkolith/Insider Trading/GNCA/Form 4

Davis Thomas Andrew

CHIEF MEDICAL OFFICERGENOCEA BIOSCIENCES, INC. (GNCA) · full profile →Form 4 · filed Mar 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2022Sell(S)3K$1.10$3K69K
Mar 15, 2022Grant(A)31K—$072K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2022Grant(A)94K—$094K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001457612-22-000028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML